Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Pakistan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Pakistan Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20083
20092
20102
20113
20121
20141
20171
20181
20196
20203
20219
20226
202311
202414
202516
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Unknown status10
Not yet recruiting10
Recruiting9
Active, not recruiting6
Terminated2
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Riphah International University18
Dow University of Health Sciences6
Getz Pharma6
Bahria University4
Novo Nordisk A/S4
GlaxoSmithKline3
Khyber Medical University Peshawar3
Lahore General Hospital3
University of Veterinary and Animal Sciences, Lahore - Pakistan3
Foundation University Islamabad2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 294
Diabetes Mellitus13
Diabetic Neuropathies6
Obesity5
Diabetic Nephropathies4
Hyperglycemia4
Hypertension4
Insulin Resistance3
Overweight3
Body Weight Changes2

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.